Facebook
Twitter
LinkedIn
ForwardeContouring for Central Nervous System
There have been many advances and evolutions in the treatment of primary and metastatic CNS tumors. There are different treatment planning and contouring guidelines for CNS tumors. Without a clear and consolidated understanding of best practices, this could affect quality of care.
This will be a focused econtouring session on primary and secondary brain tumors, including the planning/treatment of CSI for leptomeningeal disease, brain SRS for intact and post operative brain metastases, and the treatment of glioma with a brief discussion and application of different MRI sequences.
Target Audience
The meeting is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, radiation therapists, radiation dosimetrists, nurses and all other health professionals involved in the field of radiation oncology.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Treatment planning for CSI.
- Contouring and planning of intact and resected brain metastases.
- MRI-specific contouring for gliomas.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
- 1.25 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.25 Certificate of AttendanceThis activity was designated for 1.25 AMA PRA Category 1 Credit™.